Inhibitory effect of dietary lipids on chaperone-mediated autophagy | PNAS
Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis | Circulation Research
Consequences of the selective blockage of chaperone-mediated autophagy | PNAS
Frontiers | Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders
Frontiers | Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders
Discovery of LAMP-2A as potential biomarkers for glioblastoma development by modulating apoptosis through N-CoR degradation | Cell Communication and Signaling | Full Text
Discovery of LAMP-2A as potential biomarkers for glioblastoma development by modulating apoptosis through N-CoR degradation | Cell Communication and Signaling | Full Text
Changes in the LAMP-2A-related protease complex at the lysosomal... | Download Scientific Diagram
Identification of Regulators of Chaperone-Mediated Autophagy - ScienceDirect
Constitutive Upregulation of Chaperone-Mediated Autophagy in Huntington's Disease | Journal of Neuroscience
Lysosome Associated Membrane Protein - an overview | ScienceDirect Topics
Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung
Selective maintained blockage of LAMP-2A expression in mouse... | Download Scientific Diagram
Figure 1 | Parkinson's Disease and Autophagy
SNX10-mediated degradation of LAMP2A by NSAIDs inhibits chaperone-mediated autophagy and induces hepatic lipid accumulation
Chaperone-mediated autophagy - Wikipedia
LAMP-2A organizes into defined protein complexes at the lysosomal... | Download Scientific Diagram
LAMP2 Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Frontiers | Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
Changes in the lysosomal degradation of LAMP-2A with age. (A) Half-life... | Download Scientific Diagram
Impairment of chaperone‐mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis | EMBO Molecular Medicine
.jpg?time=20220826?time=20220826 "LAMP-2A Polyclonal Antibody (AMC2) (51-2200)")
LAMP-2A Polyclonal Antibody (AMC2) (51-2200)
Discovery of LAMP-2A as potential biomarkers for glioblastoma development by modulating apoptosis through N-CoR degradation | Cell Communication and Signaling | Full Text
Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinoma
Constitutive Upregulation of Chaperone-Mediated Autophagy in Huntington's Disease | Journal of Neuroscience
